| Date | Time | Source | Headline | Symbol | Company |
| 07/10/2009 | 22:08 | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(5) (424B5) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/10/2009 | 11:19 | Edgar (US Regulatory) | Free Writing Prospectus - Filing under Securities Act Rules 163/433 (FWP) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/10/2009 | 11:14 | Business Wire | Allos Therapeutics Announces Pricing of Public Offering of Common Stock | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/10/2009 | 21:08 | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(5) (424B5) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/10/2009 | 21:06 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/10/2009 | 21:01 | Business Wire | Allos Therapeutics Announces Proposed Public Offering of Common Stock | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/10/2009 | 13:12 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/10/2009 | 12:00 | Business Wire | Allos Therapeutics Announces U.S. Availability of FOLOTYN™ (pralatrexate injection) for Relapsed or Refractory Peripheral T... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 02/10/2009 | 22:53 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 01/10/2009 | 11:36 | Marketwired | RothmanResearch.com Stock Review for SCG, CA, NE, MKC, COL and ALTH | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 25/09/2009 | 13:45 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 25/09/2009 | 12:00 | Business Wire | Allos Therapeutics’ FOLOTYN™ First and Only FDA-Approved Therapy for Relapsed or Refractory Peripheral T-cell Lymphoma | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/09/2009 | 21:15 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/09/2009 | 13:52 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 02/09/2009 | 23:09 | Business Wire | Allos Therapeutics Announces FDA Advisory Committee Recommends Accelerated Approval of FOLOTYN™ (pralatrexate) for the Trea... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 02/09/2009 | 11:00 | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 01/09/2009 | 14:05 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 01/09/2009 | 13:00 | Business Wire | Allos Therapeutics to Hold Post Advisory Committee Conference Call | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 31/08/2009 | 14:31 | PR Newswire (US) | Seven Summits Research Releases Comments on Boeing, Joy Global, Ciena Corporation, TakeTwo Interactive and Allos Therapeutics | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 28/08/2009 | 18:27 | Dow Jones News | FDA Has Several Issues With Allos Data For Folotyn | NASDAQ:ALTH | Allos Therapeutics Inc. |
| 14/08/2009 | 21:16 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 12/08/2009 | 23:01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 12/08/2009 | 22:59 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/08/2009 | 21:04 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/08/2009 | 15:25 | Business Wire | Allos Therapeutics Announces FDA Advisory Committee to Review Pralatrexate for the Treatment of Patients with Relapsed or Ref... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/08/2009 | 23:01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/08/2009 | 23:03 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/08/2009 | 23:01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 04/08/2009 | 22:16 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 04/08/2009 | 21:06 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |